792 related articles for article (PubMed ID: 32015683)
41. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
[TBL] [Abstract][Full Text] [Related]
42. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
43. Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/β-catenin signalling pathway and is a potential diagnostic biomarker.
Li N; Li J; Mi Q; Xie Y; Li P; Wang L; Binang H; Wang Q; Wang Y; Chen Y; Wang Y; Mao H; Du L; Wang C
J Cell Mol Med; 2020 Oct; 24(19):11318-11329. PubMed ID: 32889785
[TBL] [Abstract][Full Text] [Related]
44. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
45. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer.
Hu X; Bao J; Wang Z; Zhang Z; Gu P; Tao F; Cui D; Jiang W
Tumour Biol; 2016 Mar; 37(3):3497-504. PubMed ID: 26453113
[TBL] [Abstract][Full Text] [Related]
46. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
[TBL] [Abstract][Full Text] [Related]
47. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer.
Wang N; Guo W; Song X; Liu L; Niu L; Song X; Xie L
Clin Chem Lab Med; 2020 Aug; 58(9):1535-1545. PubMed ID: 32271158
[TBL] [Abstract][Full Text] [Related]
48. Circulating Serum Exosomal Long Non-Coding RNAs FOXD2-AS1, NRIR, and XLOC_009459 as Diagnostic Biomarkers for Colorectal Cancer.
Yu M; Song XG; Zhao YJ; Dong XH; Niu LM; Zhang ZJ; Shang XL; Tang YY; Song XR; Xie L
Front Oncol; 2021; 11():618967. PubMed ID: 33777763
[TBL] [Abstract][Full Text] [Related]
49. Expression and Clinical Significance of lncRNA OSER1-AS1 in Peripheral Blood of Patients with Non-Small Cell Lung Cancer.
Chen P; Qin Z; Sun X; Yang J; Lv J; Diao M
Cells Tissues Organs; 2022; 211(5):589-600. PubMed ID: 34525476
[TBL] [Abstract][Full Text] [Related]
50. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
51. Serum exosomal hsa_circ_0069313 has a potential to diagnose more aggressive non-small cell lung cancer.
Chen Y; Lou C; Ma X; Zhou C; Zhao X; Li N; Tian H; Meng X
Clin Biochem; 2022 Apr; 102():56-64. PubMed ID: 35077682
[TBL] [Abstract][Full Text] [Related]
52. A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma.
Xie K; Zheng C; Gu W; Jiang Z; Luo C; Luo J; Diao Y; Wang G; Cong Z; Yao X; Hu L; Shen Y
Thorac Cancer; 2022 Dec; 13(23):3341-3352. PubMed ID: 36266257
[TBL] [Abstract][Full Text] [Related]
53. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer.
Lin LY; Yang L; Zeng Q; Wang L; Chen ML; Zhao ZH; Ye GD; Luo QC; Lv PY; Guo QW; Li BA; Cai JC; Cai WY
Mol Cancer; 2018 Apr; 17(1):84. PubMed ID: 29690888
[TBL] [Abstract][Full Text] [Related]
54. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer.
Zhang ZJ; Song XG; Xie L; Wang KY; Tang YY; Yu M; Feng XD; Song XR
Exp Biol Med (Maywood); 2020 Oct; 245(16):1428-1436. PubMed ID: 32741216
[TBL] [Abstract][Full Text] [Related]
55. EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88/NF-κb signaling.
Xu Q; Zhao T; Han H; Fan J; Xie W
Thorac Cancer; 2023 Feb; 14(5):450-461. PubMed ID: 36541122
[TBL] [Abstract][Full Text] [Related]
56. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
57. ZEB1-AS1 is associated with poor prognosis in non-small-cell lung cancer and influences cell migration and apoptosis by repressing ID1.
Jin J; Wang H; Si J; Ni R; Liu Y; Wang J
Clin Sci (Lond); 2019 Jan; 133(2):381-392. PubMed ID: 30626729
[TBL] [Abstract][Full Text] [Related]
58. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
Lu Z; Li Y; Che Y; Huang J; Sun S; Mao S; Lei Y; Li N; Sun N; He J
Cancer Lett; 2018 Sep; 432():156-168. PubMed ID: 29908210
[TBL] [Abstract][Full Text] [Related]
59. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.
Li C; Li C; Zhi C; Liang W; Wang X; Chen X; Lv T; Shen Q; Song Y; Lin D; Liu H
J Transl Med; 2019 Oct; 17(1):355. PubMed ID: 31665020
[TBL] [Abstract][Full Text] [Related]
60. Evaluating the expression of tumorigenic long noncoding RNAs in circulating exosomes isolated from non-small-cell lung cancer patients.
Shi Z; Huang K; Li Z; Niu Y; Jiang L
Biomark Med; 2022 Mar; 16(4):241-251. PubMed ID: 35209738
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
